Результаты поиска - Roderich E. Schwarz

  • Отображение 1 - 16 результаты of 16
Отмена результатов
  1. 1
    Profile of nintedanib in the treatment of solid tumors: the evidence to date

    Profile of nintedanib in the treatment of solid tumors: the evidence to date по Niranjan Awasthi, Roderich E. Schwarz

    Опубликовано 2015
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  2. 2
    Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial

    Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial по Roderich E. Schwarz, David Smith

    Опубликовано 2005
    Полный текст Полный текст
    Carta
    Добавить в Избранное
    Сохранить в:
  3. 3
    Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.

    Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. по Roderich E. Schwarz, Jeffrey S. Groeger, Daniel G. Coit

    Опубликовано 1997
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    Subcutaneously implanted central venous access devices in cancer patients

    Subcutaneously implanted central venous access devices in cancer patients по Roderich E. Schwarz, Jeffrey S. Groeger, Daniel G. Coit

    Опубликовано 1997
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    BMS-754807, a Small-Molecule Inhibitor of Insulin-like Growth Factor-1 Receptor/Insulin Receptor, Enhances Gemcitabine Response in Pancreatic Cancer

    BMS-754807, a Small-Molecule Inhibitor of Insulin-like Growth Factor-1 Receptor/Insulin Receptor, Enhances Gemcitabine Response in Pancreatic Cancer по Niranjan Awasthi, Changhua Zhang, Winston Ruan, Margaret A. Schwarz, Roderich E. Schwarz

    Опубликовано 2012
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling

    Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling по Niranjan Awasthi, Margaret A. Schwarz, Varun Verma, Clint D. Cappiello, Roderich E. Schwarz

    Опубликовано 2008
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer

    Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer по Niranjan Awasthi, Stefan Hinz, Rolf A. Brekken, Margaret A. Schwarz, Roderich E. Schwarz

    Опубликовано 2014
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    Functional and phenotypic analysis of tumor-infiltrating. Lymphocytes isolated from human primary and metastatic. Liver tumors and cultured in recombinant interleukin-2

    Functional and phenotypic analysis of tumor-infiltrating. Lymphocytes isolated from human primary and metastatic. Liver tumors and cultured in recombinant interleukin-2 по Shojiro Takagi, Kangnian Chen, Roderich E. Schwarz, Shunzaburo Iwatsuki, Ronald B. Herberman, Theresa L. Whiteside

    Опубликовано 1989
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  9. 9
    Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement

    Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement по Roderich E. Schwarz, Jordan Berlin, Heinz Josef Lenz, Bernard Nordlinger, Laura Rubbia‐Brandt, Michael A. Choti

    Опубликовано 2012
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  10. 10
    PG545, an Angiogenesis and Heparanase Inhibitor, Reduces Primary Tumor Growth and Metastasis in Experimental Pancreatic Cancer

    PG545, an Angiogenesis and Heparanase Inhibitor, Reduces Primary Tumor Growth and Metastasis in Experimental Pancreatic Cancer по Katherine T. Ostapoff, Niranjan Awasthi, Bercin Kutluk Cenik, Stefan Hinz, Keith Dredge, Roderich E. Schwarz, Rolf A. Brekken

    Опубликовано 2013
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  11. 11
    Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement

    Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement по Roderich E. Schwarz, Ghassan K. Abou‐Alfa, Jeffrey F. Geschwind, Sunil Krishnan, Riad Salem, Alan P. Venook

    Опубликовано 2010
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  12. 12
    Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer

    Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer по Niranjan Awasthi, Chenyue Zhang, Anna Schwarz, Stefan Hinz, C. Wang, Noelle S. Williams, Margaret A. Schwarz, Roderich E. Schwarz

    Опубликовано 2013
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  13. 13
    Apricoxib, a Novel Inhibitor of COX-2, Markedly Improves Standard Therapy Response in Molecularly Defined Models of Pancreatic Cancer

    Apricoxib, a Novel Inhibitor of COX-2, Markedly Improves Standard Therapy Response in Molecularly Defined Models of Pancreatic Cancer по Amanda Kirane, Jason E. Toombs, Katherine T. Ostapoff, Juliet G. Carbon, Sara Zaknoen, Jordan Braunfeld, Roderich E. Schwarz, Francis Burrows, Rolf A. Brekken

    Опубликовано 2012
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  14. 14
    Endothelial-Monocyte Activating Polypeptide Ii, a Novel Antitumor Cytokine That Suppresses Primary and Metastatic Tumor Growth and Induces Apoptosis in Growing Endothelial Cells

    Endothelial-Monocyte Activating Polypeptide Ii, a Novel Antitumor Cytokine That Suppresses Primary and Metastatic Tumor Growth and Induces Apoptosis in Growing Endothelial Cells по Margaret A. Schwarz, Jessica J. Kandel, Jerald Brett, Jun Li, Joanne Hayward, Roderich E. Schwarz, Olivier Chappey, Jean-Luc Wautier, John A. Chabot, Paul Lo Gerfo, David M. Stern

    Опубликовано 1999
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases

    A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases по Jeffrey Meyer, Ryan Foster, Naama Lev‐Cohain, Takeshi Yokoo, Ying Dong, Roderich E. Schwarz, William G. Rule, Jing Tian, Yang Xie, Raquibul Hannan, Lucien Nedzi, Timothy D. Solberg, Robert Timmerman

    Опубликовано 2015
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  16. 16
    Alternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) Phase II Intergroup Trial, N9945/CI-66

    Alternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/ National Surgical Adj... по Steven R. Alberts, Mark S. Roh, Michelle R. Mahoney, Michael J. OʼConnell, David M. Nagorney, Lawrence D. Wagman, Thomas C. Smyrk, Timothy L. Weiland, Lily Lai, Roderich E. Schwarz, R Molina, Todor Dentchev, John S. Bolton

    Опубликовано 2010
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: